Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 191

    1.

    Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A.

    Diabetes. 2005 Sep;54(9):2596-601.PMID: 16123347 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.
    3.

    Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A.

    Diabetes. 2008 Dec;57(12):3281-8. Epub 2008 Oct 3.PMID: 18835930 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass.

    Suarez-Pinzon WL, Lakey JR, Brand SJ, Rabinovitch A.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3401-9. Epub 2005 Mar 15.PMID: 15769977 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin.

    Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y.

    Pharmacol Toxicol. 2002 Dec;91(6):414-20. Review.PMID: 12688387 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan.

    Rooman I, Bouwens L.

    Diabetologia. 2004 Feb;47(2):259-65. Epub 2003 Dec 10.PMID: 14666367 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

    Ogawa N, List JF, Habener JF, Maki T.

    Diabetes. 2004 Jul;53(7):1700-5.PMID: 15220193 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

    Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL.

    J Clin Invest. 2001 Jul;108(1):63-72.PMID: 11435458 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.

    Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS.

    Diabetes. 1999 May;48(5):989-96.PMID: 10331402 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice.

    Pechhold K, Koczwara K, Zhu X, Harrison VS, Walker G, Lee J, Harlan DM.

    PLoS One. 2009;4(3):e4827. Epub 2009 Mar 16.PMID: 19287497 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer system.

    Yamada S, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Irie J, Saruta T.

    Ann N Y Acad Sci. 2003 Nov;1005:211-4.PMID: 14679061 [PubMed - indexed for MEDLINE]Related articles

    14.

    Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

    Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC.

    Endocrinology. 2007 Nov;148(11):5136-44. Epub 2007 Aug 2.PMID: 17673522 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system.

    Yamada S, Irie J, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Saruta T.

    Autoimmunity. 2003 Mar;36(2):63-70.PMID: 12820687 [PubMed - indexed for MEDLINE]Related articles

    17.

    Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice.

    Ninova D, Dean PG, Stegall MD.

    J Autoimmun. 2004 Nov;23(3):201-9.PMID: 15501391 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regenerative and therapeutic effects of heparin-binding epidermal growth factor-like growth factor on diabetes by gene transduction through retrograde pancreatic duct injection of adenovirus vector.

    Kozawa J, Tokui Y, Moriwaki M, Li M, Ohmoto H, Yuan M, Zhang J, Iwahashi H, Imagawa A, Yamagata K, Tochino Y, Shimomura I, Higashiyama S, Miyagawa J.

    Pancreas. 2005 Jul;31(1):32-42.PMID: 15968245 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.

    Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.

    Diabetes. 2007 Oct;56(10):2561-8. Epub 2007 Jul 9.PMID: 17620422 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data